info@seagull-health.com
SeagullHealth
语言:
search
new
What are the Indications for Amlodipine?
501
Article source: Seagull Pharmacy
Dec 17, 2025

Amlodipine is a long-acting calcium channel blocker that plays an important role in the treatment of cardiovascular diseases. Its orally disintegrating tablet (ODT) formulation further enhances the convenience of administration through a unique manufacturing process, making it particularly suitable for patients with dysphagia or those requiring rapid onset of action.

What are the Indications for Amlodipine?

Hypertension Treatment

Amlodipine orally disintegrating tablets are indicated for the treatment of patients with hypertension at all stages, either as monotherapy or in combination with other antihypertensive drugs.

Its antihypertensive mechanism stems from a direct effect on vascular smooth muscle: by inhibiting calcium ion influx, it effectively reduces peripheral vascular resistance.

Chronic Stable Angina Pectoris

For patients diagnosed with chronic stable angina pectoris, this product can significantly alleviate exercise-induced angina symptoms.

Its mechanism of action includes reducing cardiac afterload and myocardial oxygen consumption without affecting heart rate, resulting in a favorable safety profile.

Vasospastic Angina Pectoris

This product has a definite therapeutic effect on variant angina pectoris.

It restores blood perfusion by inhibiting coronary artery spasm.

It is important to note that caution should be exercised when administering this drug to patients with severe aortic stenosis. Exacerbation of angina pectoris has been occasionally reported when initiating calcium channel blocker therapy, requiring close monitoring.

Dosage Forms, Specifications and Characteristics of Amlodipine

Dosage Form Design and Specifications

Amlodipine orally disintegrating tablets adopt oral disintegration technology and are available in three specifications: 2.5 mg, 5 mg and 10 mg (all calculated as amlodipine).

Its unique advantage is that it can disintegrate rapidly in the oral cavity without the need for water, and is swallowed and absorbed via saliva, which greatly improves medication compliance.

Appearance Identification Characteristics

The 2.5 mg tablet is a white, round, biconvex tablet engraved with "ADP2.5" and "ODT".

The 5 mg tablet is light yellow and marked with "ADP5".

The 10 mg tablet is pink and labeled with "ADP10".

Composition

Active ingredient: Amlodipine besylate.

Excipients: The tablet also contains a variety of excipients, including hydroxypropyl cellulose (stabilizer), iron oxide red (colorant for 10 mg tablets), iron oxide yellow (colorant for 5 mg tablets), magnesium stearate (lubricant), menthol (flavoring agent), silicified microcrystalline cellulose (disintegrant) and sucralose (sweetener).

Storage Method for Amlodipine

Environmental Requirements

This product should be stored at room temperature between 20°C and 25°C (68°F and 77°F), with short-term storage permitted in the range of 15°C to 30°C (59°F to 86°F).

Special attention should be paid to light protection to avoid ingredient degradation caused by direct sunlight.

Container Selection

It must be stored in a sealed, light-resistant dedicated container.

In daily management, the medicine should not be placed in high-humidity places such as bathrooms to prevent moisture absorption that may affect its efficacy.

Special Precautions

Ensure the bottle cap is tightly closed after opening to avoid moisture absorption.

Tablets of different specifications should be stored separately to prevent confusion.

For household storage, place the medicine in a safe location out of the reach of children to avoid accidental ingestion.

Note: For internal discussion among medical personnel only. For specific medication, please consult the attending physician. Drug information may change over time. For the latest information, we recommend adding a medical consultant or consulting for free online.
Recommended Articles
Where to Purchase Amlodipine
Amlodipine is a long-acting calcium channel blocker widely used in the treatment of hypertension, chronic stable angina pectoris, and vasospastic angina pectoris. As a prescription drug, its standardi...
Adverse Reactions of Pemigatinib (Pemazyre)
Pemigatinib (Pemazyre) is a targeted therapy indicated for the treatment of specific types of cholangiocarcinoma and myeloid/lymphoid neoplasms (MLN) with FGFR1 rearrangement.Adverse Reactions of Pemi...
What are the Precautions for Taking Pemigatinib (Pemazyre)?
Pemigatinib (Pemazyre) is an important targeted therapy for specific gene mutations, playing a pivotal role in the treatment of advanced cholangiocarcinoma and myeloid/lymphoid neoplasms (MLN) with FG...
What are the Indications for Pemigatinib (Pemazyre)?
Pemigatinib (Pemazyre) is an innovative kinase inhibitor. By specifically targeting the fibroblast growth factor receptor (FGFR) pathway, it provides a precision treatment option for patients with mal...
Dosage and Administration of Amlodipine - Recommended Doses
Amlodipine is a long-acting dihydropyridine calcium channel blocker, widely used in the treatment of hypertension and angina pectoris.Dosage and Administration of Amlodipine - Recommended DosesDosage ...
Dosage and Administration of Pemigatinib (Pemazyre) - Recommended Doses
Pemigatinib (Pemazyre) is a targeted therapy for specific genetic abnormalities, mainly indicated for the treatment of cholangiocarcinoma with FGFR2 genetic abnormalities and myeloid/lymphoid neoplasm...
Where to Purchase Sitagliptin/Metformin Hydrochloride Extended-Release Tablets (Janumet XR)
Sitagliptin/Metformin Hydrochloride Extended-Release Tablets (Janumet XR) is an important medication for the treatment of type 2 diabetes mellitus. Patients pay close attention to issues such as the l...
What are the Indications for Sitagliptin/Metformin Extended-Release Tablets (Janumet XR)?
Sitagliptin/Metformin Extended-Release Tablets (Janumet XR) is a novel fixed-dose combination antihyperglycemic medication. It integrates two hypoglycemic ingredients with distinct mechanisms of actio...
Related Articles
Dosage and Administration, Recommended Dosage of Capmatinib (Tabrecta)
Capmatinib (Tabrecta) is a highly selective MET inhibitor, offering a precision treatment option for patients with metastatic non-small cell lung cancer (NSCLC) harboring MET exon 14 skipping mutation...
What Are the Indications for Capmatinib (Tabrecta)?
Capmatinib (Tabrecta) is a targeted therapy medication that plays an important role in the treatment of non-small cell lung cancer associated with specific gene mutations. As a MET kinase inhibitor, i...
What Are the Purchase Channels for Capmatinib (Tabrecta)?
Capmatinib (Tabrecta) is a highly selective MET inhibitor that has demonstrated significant efficacy in patients with metastatic non-small cell lung cancer (NSCLC) harboring MET exon 14 skipping mutat...
Adverse Reactions of Ivosidenib (Tibsovo)
Ivosidenib (Tibsovo) is an isocitrate dehydrogenase 1 (IDH1) inhibitor, primarily indicated for the treatment of patients with acute myeloid leukemia, myelodysplastic syndromes, and cholangiocarcinoma...
What Are the Precautions for Using Ivosidenib (Tibsovo)?
Ivosidenib (Tibsovo) is a targeted therapy medication primarily indicated for the treatment of patients with malignant hematologic diseases harboring specific gene mutations.What Are the Precautions f...
Dosage and Administration, Recommended Dosage of Ivosidenib (Tibsovo)
Ivosidenib (Tibsovo) is a targeted isocitrate dehydrogenase 1 (IDH1) inhibitor that demonstrates significant value in the treatment of malignant tumors with specific gene mutations.Dosage and Administ...
What Are the Indications for Ivosidenib (Tibsovo)?
Ivosidenib (Tibsovo) is an oral isocitrate dehydrogenase-1 (IDH1) inhibitor indicated for patients with various malignant tumors harboring specific IDH1 gene mutations. By inhibiting the activity of m...
What Are the Purchase Channels for Ivosidenib (Tibsovo)?
Ivosidenib (Tibsovo) is an important targeted therapy drug against IDH1 mutations, demonstrating significant efficacy in diseases such as acute myeloid leukemia and cholangiocarcinoma. For patients in...
New Drugs
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Faricimab-svoa(Vabysmo)
Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • mailbox:info@lucius.la
Welcome to consult
ucius Pharmaceuticals (Lao) Co.,Ltd All rights reserved